A Case of Crohn's Disease with Increased CD8 T-Cell Activation and Remission during Therapy with Intravenous Immunoglobulins

References

• Brandtzaeg P, Halstensen TS, Kett K, Rognum TO. Local immunopathology in inflammatory bowel disease. In: Jarnerot G, editor. Inflammatory bowel diseases. New York: Raven Press; 1987. p. 21.
   Google Scholar
• James SP. Role of immunoregulatory mechanisms in the pathogenesis of inflammatory bowel disease. In: Jarnerot G, editor. Inflammatory bowel diseases. New York: Raven Press; 1987. p. 37.
   Google Scholar
• Imbach P, d’Apuzza V, Hirt A, Rossi E, Vest M, Barandum S, Baumgartner C, et al. High dose intravenous gamma globulin for idiopathic thrombocytopenia purpura in childhood. Lancet 1981;1:1128–30.
   Google Scholar
• Newburger JW, Takahashi M, Burns JC, Beiser AS, Chung KJ, Duffy CE, et al. The treatment of Kawasaki syndrome with intravenous gamma globulin. N Engl J Med 1986;315:341–7.
   PubMed Web of Science ®Google Scholar
• Imbach P, Jungi TW. Possible mechanisms of IVIG treatment in childhood idiopathic thrombocytopenic purpura (ITP). Blood 1983;46:117–24.
   Google Scholar
• Sultan Y, Kazatchkine MD, Maisoneuve P, Nydegger UE. Antiidiotypic suppression of autoantibodies to factor VIII by high dose intravenous gamma globulin. Lancet 1985;2:756–68.
   PubMedGoogle Scholar
• MacDermott RP, Bragdon MJ, Thurmon RD. Peripheral blood mononuclear cells from patients with inflammatory bowel disease exhibit normal functions in the allogeneic and autologous mixed leukocyte reaction and cell-mediated lympholysis. Gastroenterology 1984;86:476.
   Google Scholar
• Holdstock G, Chastenay BF, Krawitt EL. Functional suppressor T cell activity in Crohn’s disease and the effects of sulphasalazine. Clin Exp Immunol 1982;48:619.
   Google Scholar
• Auer IO, Buschmann CH, Ziemer E. Immune status in Crohn’s disease. Gut 1978;19:618.
   PubMedGoogle Scholar
• Kramer JK, Depew WT, Szewczuk MR. T-cell immunoregulation in patients with inflammatory bowel disease. I. Differential helper T-cell function in ulcerative colitis and Crohn’s disease. J Clin Lab Immunol 1988;25:9–17.
   Google Scholar
• Senju M, Hulstaert F, Lowder J, Jewell DP. Flow cytometric analysis of peripheral blood lymphocytes in ulcerative colitis and Crohn’s disease. Gut 1991;32:779–83.
   PubMed Web of Science ®Google Scholar
• Hodgson JHF, Wands JR, Isselbacher KJ. Decreased suppressor cell activity in inflammatory bowel disease. Clin Exp Immunol 1978;32:452.
   Google Scholar
• Doldi K, Manger B, Koch B. Spontaneous suppresso cell activity in the peripheral blood of patients with malignant and chronic inflammatory bowel disease. Clin Exp Immunol 1984; 55:655.
   Google Scholar
• Goodacre RL, Bienenstock J. Reduced suppressor cell activity in intestinal lymphocytes from patients with Crohn's disease. Gastroenterology 1982;82:653.
   PubMedGoogle Scholar
• Ginsburg CH, Falchuk ZM. Defective autologous mixedlymphocyte reaction and suppressor cell generation in patients with inflammatory bowel disease. Gastroenterology 1982;83:1.
   PubMed Web of Science ®Google Scholar
• Godin NJ, Sachar DB, Winchester R, Simon C, Janowitz HD. Loss of suppressor T-cells in active inflammatory bowel disease. Gut 1984;25:743.
   Google Scholar
• Fiocchi C, Youngman KR, Farmer RG. Immunoregulatory function of human intestinal mucosa lymphoid cells: evidence for enhanced suppressor cell activity in inflammatory bowel disease. Gut 1983;24: 692.
   Google Scholar
• Elson CO, Graeff AS, James SP, Strober W. Covert suppressor T cells in Crohn’s disease. Gastroenterology 1981;80:1513.
   PubMed Web of Science ®Google Scholar
• James SP, Neckers LM, Graeff AS, Cossman J. Suppression of immunoglobulin synthesis by lmyphocyte subpopulations in patients with Crohn’s disease. Gastroenterology 1984;86:1510.
   PubMed Web of Science ®Google Scholar
• Danis VA, Heatley RV. Pokeweed mitogen stimulated immunoglobulin production by peripheral blood lymphocytes in vitro: evidence for disordered immunoregulation in patients with ulcerative colitis and Crohn’s disease. Clin Exp Immunol 1983; 54:739.
   PubMedGoogle Scholar
• James SP, Neckers LM, Graefft AS, Cossman J, Balch CM, Strober W. Suppression of Immunoglobulin synthesis by lymphocyte subpopulations in patients with Crohn’s disease. Gastroenterology 1984;86:1510–8.
   PubMed Web of Science ®Google Scholar
• DeKruyff RH, Simonson BG, Siskind GW. Cellular interactions in immune regulation. Hapten specific suppression by non-T cells and T cell mediated reversal of suppression. J Exp Med 1981;154:1188–200.
   Google Scholar
• Gershon RK, Eardley DD, Durum S, et al. Contrasuppression. A novel immunoregulatory activity. J Exp Med 1981;153:1533–46.
   PubMed Web of Science ®Google Scholar
• Yamaguchi K, Green DR, Eardley DD, Murphy DB, Gershon RK. Immunoregulatory circiuts that modulate responsiveness to suppressor cell signals. Failure of B10 mice to respond to suppressor factors can be overcome by quenching the controsuppressor circuit. J Exp Med 1982;153: 1547–61.
   Google Scholar
• Fillit H, Bernstein L, Davidson M, Brandt L, Bezahler G, Cohen M, et al. Primary acquired hypogammaglobulinemia and regional enteritis. Arch Intern Med 1977;137:1252–4.
   PubMedGoogle Scholar
• Waldmann TA, Schwab PJ. IgA (7S gamma globulin) metabolism in hypogammaglobulinemia: studies in patients with defective gamma globulin synthesis, gastrointestinal loss or both. J Clin Invest 1965;44:1523–33.
   PubMed Web of Science ®Google Scholar
• Eggert RC, Wilson ID, Good RA. Agammaglobulinemia and regional enteritis. Ann Intern Med 1969;71:581–5.
   PubMed Web of Science ®Google Scholar
• Soltoft J, Peterson L, Kruse P. Immunoglobulin deficiency and regional enteritis. Scand J Gastroenterol 1972;7:233–6.
   PubMedGoogle Scholar
• MacDermott RP, Bragdon MJ, Jenkins KM, Franklin GO, Shedlofsky S, Kidner IJ. Human intestinal mononuclear ells. II. Demonstration of a naturally occuring subclass of T cells which respond in the allogeneic mixed leukocyte reaction but do not effect cell-mediated lympholysis. Gastroenterology 1981;80: 748.
   Google Scholar
• Holdstock G, Ershler WB, Krawitt EL. Defective lymphocyte IgA production in inflammatory bowel disease. Clin Immunol Immunopathol 1982;24:47.
   Google Scholar
• MacDermott RP, Nash GS, Auer IO, Shlien R, Lewis BS, Madassery J, et al. Alterations in serum immunoglobulin G subclasses in patients with ulcerative colitis and Crohn disease. Gastroenterology 1989;96:764–8.
   PubMed Web of Science ®Google Scholar
• Amran D, Renz H, Lack G, Bradley K, Gelfand EW. Suppression of cytokine-dependent human T-cell proliferation by intravenous immunoglobulin. Clin Immunol Immunopathol 1994;73:180–6.
   Google Scholar
• Wolf A, Gaedicke G, Leupold D, Krohne E. Treatment of morbus Crohn with intravenous immunoglobulin. Monatsschr Kinderheilkd 1988;136:101–3.
   PubMedGoogle Scholar
• Rohr G, Kusterer K, Schille M, Gladisch R, Schedes U, Teuber J, et al. Treatment of Crohn’s disease and ulcerative colitis with 7S-immunoglobulin. Lancet 1987;1:170.
   PubMedGoogle Scholar